As of 12/31/2024, Tracenable has captured detailed data on Eli Lilly and Co's corporate ownership structure, providing a comprehensive view of its downstream entities and the role within the broader group hierarchy.a
The dataset includes information on 153 affiliated entities, encompassing subsidiaries, joint ventures, associates, and other related companies in which Eli Lilly and Co holds an equity interest or exercises control as the ultimate parent.a
Tracenable's data also records effective ownership percentages that Eli Lilly and Co holds across these entities, providing transparency into its corporate control, ownership hierarchy, and group governance practices.a
| Entity Name | Country | Type | Ownership | LEI | PermID |
|---|---|---|---|---|---|
Balance Pharmacy Services, LLCa | USA | Not Specified | 0000000 | 0000000 | |
CoLucid Pharmaceuticals, Inc.a | USA | Not Specified | 0000000 | 0000000 | |
Compania Farmaceutica Eli Lilly de Centro America S.A.a | GTM | Not Specified | 0000000 | 0000000 | |
Dermira, Inc.a | USA | Not Specified | 0000000 | 0000000 | |
DICE Alpha, Inc.a | USA | Not Specified | 0000000 | 0000000 | |
DICE Molecules SV, Inc.a | USA | Not Specified | 0000000 | 0000000 | |
DICE Therapeutics, Inc.a | USA | Not Specified | 0000000 | 0000000 | |
Disarm Therapeutics, Inc.a | USA | Not Specified | 0000000 | 0000000 | |
Dista Ilac Ticaret Limited Sirketia | TUR | Not Specified | 0000000 | 0000000 | |
Dista, S.A.a | ESP | Not Specified | 0000000 | 0000000 | |
Dista-Produtos Quimicos & Farmaceuticos, LDAa | PRT | Not Specified | 0000000 | 0000000 | |
Elanco Animal Health Ireland Limiteda | IRL | Not Specified | 0000000 | 0000000 | |
| 0000000 | 0000000 | 0000000 | 0000000 | 0000000 | 0000000 |
| 0000000 | 0000000 | 0000000 | 0000000 | 0000000 | 0000000 |
| Showing 12 out of 153 entities. Get complete coverage in the full dataset. | |||||
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Eli Lilly and Co’s data sources below and access millions more through our Disclosure Search.
Tracenable's dataset provides geographic insights into Eli Lilly and Co's group entities, revealing where its subsidiaries, joint ventures, associates, and affiliates are located worldwide.a
In total, the Eli Lilly and Co group consists of 153 entities distributed across 54 countries, reflecting the company's global footprint and jurisdictional presence.a
This visualization highlights the geographical distribution of Eli Lilly and Co's corporate structure, helping assess its international exposure, operational reach, and cross-border governance landscape.a
In 2024, Tracenable identified that the Eli Lilly and Co group consisted of 153 entities operating across 54 countries.a
This indicates a high geographic diversification, reflecting Eli Lilly and Co's expansion strategy, global footprint, and cross-border exposure.a
Eli Lilly and Co's subsidiaries and affiliates are primarily concentrated in North America and Europe, which host 80.39% of its total entities.a
This regional distribution suggests that Eli Lilly and Co's operational and financial activities are centered in these markets, either due to core business operations, supply chain proximity, or favorable regulatory environments.
Eli Lilly and Co shows a moderate to high level of transparency regarding its ownership structure.
The disclosure includes information on subsidiaries, joint ventures, and associates, allowing partial visibility into the company's downstream relationships and areas of shared control.a
While not a full edge-level disclosure, the data still provides meaningful insight into Eli Lilly and Co's governance framework and group composition, positioning it among more transparent reporters in its industry.
Yes. Tracenable's data shows that 7 entities (4.58%) are registered in jurisdictions commonly classified as low-tax or offshore financial centers, such as Cayman Islands or Bermuda.a
This may indicate tax optimization strategies or the use of special-purpose vehicles (SPVs) within Eli Lilly and Co's ownership structure.